Suppr超能文献

白细胞 Rac 相关卷曲螺旋蛋白激酶活性升高预测冠状动脉痉挛性心绞痛的存在和严重程度。

Increased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina.

机构信息

Department of Cardiology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Keelung, Taiwan.

出版信息

Atherosclerosis. 2012 Apr;221(2):521-6. doi: 10.1016/j.atherosclerosis.2012.01.001. Epub 2012 Jan 12.

Abstract

OBJECTIVE

Although inhibition of Rho-associated coiled-coil containing protein kinase (ROCK) has been shown to prevent coronary vasospastic angina (CVA), direct evidence linking ROCK activity and CVA is lacking. Accordingly, we investigated whether ROCK activity is an independent marker for CVA and is altered after treatment with antispastic medications.

METHODS AND RESULTS

We prospectively studied 31 Taiwanese patients who were diagnosed with CVA and 33 control subjects. Subject demographics were recorded, and blood samples were obtained at baseline in all participants and in CVA patients after 3 months of antispastic treatment. Compared with control subjects, leukocyte ROCK activity was greater in CVA patients (136% versus 91%, P<0.001). A cutoff value for leukocyte ROCK activity of 104% predicted the presence of CVA with specificity and sensitivity rates of 88% and 84%, respectively. ROCK activity increased with the severity of CVA (P for trend<0.001). Following 3-month treatment of antispastic agents, leukocyte ROCK activity, high-sensitivity C-reactive protein, and interleukin-6 levels were reduced by 43%, 42% and 27%, respectively (P<0.05 for all).

CONCLUSIONS

Increased levels of leukocyte ROCK activity independently predicted the presence of CVA and correlated with CVA severity. Treatment with antispastic agents substantially reduced the level of leukocyte ROCK activity.

摘要

目的

尽管 Rho 相关卷曲螺旋蛋白激酶(ROCK)抑制已被证实可预防冠状动脉痉挛性心绞痛(CVA),但与 CVA 相关的 ROCK 活性的直接证据仍然缺乏。因此,我们研究了 ROCK 活性是否为 CVA 的独立标志物,以及在抗痉挛药物治疗后是否发生改变。

方法和结果

我们前瞻性研究了 31 例被诊断为 CVA 的台湾患者和 33 例对照者。记录了受试者的人口统计学数据,并在所有参与者和 CVA 患者接受 3 个月抗痉挛治疗后获得了基线时的血液样本。与对照组相比,CVA 患者的白细胞 ROCK 活性更高(136%比 91%,P<0.001)。白细胞 ROCK 活性的截断值为 104%,预测 CVA 的特异性和敏感性分别为 88%和 84%。ROCK 活性随 CVA 的严重程度而增加(趋势 P<0.001)。在接受抗痉挛药物治疗 3 个月后,白细胞 ROCK 活性、高敏 C 反应蛋白和白细胞介素-6 水平分别降低了 43%、42%和 27%(P<0.05)。

结论

白细胞 ROCK 活性升高可独立预测 CVA 的存在,并与 CVA 严重程度相关。抗痉挛药物治疗可显著降低白细胞 ROCK 活性。

相似文献

2
Increased Rho kinase activity in a Taiwanese population with metabolic syndrome.台湾代谢综合征人群中Rho激酶活性增加。
J Am Coll Cardiol. 2007 Apr 17;49(15):1619-1624. doi: 10.1016/j.jacc.2006.12.043. Epub 2007 Apr 2.

引用本文的文献

3
Relationship between Inflammation and Vasospastic Angina.炎症与血管痉挛性心绞痛的关系。
Medicina (Kaunas). 2023 Feb 9;59(2):318. doi: 10.3390/medicina59020318.
7
Coronary Artery Spasm: New Insights.冠状动脉痉挛:新的认识。
J Interv Cardiol. 2020 May 14;2020:5894586. doi: 10.1155/2020/5894586. eCollection 2020.
8
The Biochemical Markers Associated with the Occurrence of Coronary Spasm.与冠状动脉痉挛发生相关的生化标志物。
Biomed Res Int. 2019 Sep 17;2019:4834202. doi: 10.1155/2019/4834202. eCollection 2019.
10

本文引用的文献

1
Rho-kinase: important new therapeutic target in cardiovascular diseases.Rho-kinase:心血管疾病治疗的新靶点。
Am J Physiol Heart Circ Physiol. 2011 Aug;301(2):H287-96. doi: 10.1152/ajpheart.00327.2011. Epub 2011 May 27.
2
Current advances in the understanding of coronary vasospasm.冠状动脉痉挛认识的当前进展
World J Cardiol. 2010 Feb 26;2(2):34-42. doi: 10.4330/wjc.v2.i2.34.
5
Statins inhibit Rho kinase activity in patients with atherosclerosis.他汀类药物可抑制动脉粥样硬化患者的Rho激酶活性。
Atherosclerosis. 2009 Aug;205(2):517-21. doi: 10.1016/j.atherosclerosis.2008.12.023. Epub 2008 Dec 24.
10
Rho kinase (ROCK) inhibitors.Rho激酶(ROCK)抑制剂。
J Cardiovasc Pharmacol. 2007 Jul;50(1):17-24. doi: 10.1097/FJC.0b013e318070d1bd.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验